UFPT UFP Technologies

UFP Technologies, Inc. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on June 14, 2023

UFP Technologies, Inc. to Present Virtually and Host 1X1 Investor Meetings at Sidoti Virtual Investor Conference on June 14, 2023

NEWBURYPORT, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. The Company today announced that Chairman & Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on June 14-15, 2023.

The presentation will begin at 10:45 A.M. ET on June 14 and can be accessed live at , or in the investor relations section of the Company's website: . UFP Technologies, Inc. will also host virtual one-on-ones with investors on Wednesday, June 14, 2023. To register for the presentation or one-on-ones, visit . Registration is free and you don't need to be a Sidoti client.

About UFP Technologies, Inc.

UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. Utilizing highly specialized foams, films and plastics, UFP converts raw materials through laminating, molding, radio frequency welding and fabricating techniques.

About Sidoti & Company

For over two decades, Sidoti & Company () has been a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $100 million-$5 billion market cap range. The firm’s approach affords companies and institutional clients a combination of high-quality research, a small- and microcap-focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. Sidoti serves 500+ institutional clients in North America.

Contacts:

Ron Lataille, CFO, UFP Technologies, Inc., tel. 978-234-0926

Jeff Elliott, Three Part Advisors, LLC, tel. 214-966-9014

Ally Cecil, Sidoti & Company LLC, tel. 212-453-7050



EN
12/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on UFP Technologies

UFP Technologies Inc: 1 director

A director at UFP Technologies Inc sold 1,473 shares at 220.123USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

UFP Technologies Announces Record Q1 Results

UFP Technologies Announces Record Q1 Results NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Thro...

 PRESS RELEASE

UFP Technologies to Report First Quarter 2025 Financial Results on May...

UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025 Conference Call Scheduled for 10:00 AM ET NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time....

 PRESS RELEASE

UFP Technologies to Present and Host Investor Meetings at the KeyBanc ...

UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP’s presentation is scheduled to begin...

 PRESS RELEASE

UFP Technologies Announces Record 2024 Results

UFP Technologies Announces Record 2024 Results NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. Net sales for 2024 were $504.4 million, 26.1% higher than 2023 sales of $400.1 million. GAAP and adjusted earnings per diluted common share outstanding (EPS) were $7.58 and $8.68 respectively. For its fourth...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch